← All studies

2026 · Sládečková et al. — Hydrogen-Rich Water as a Performance-Enhancing Aid in National-Level Finswimmers: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

Original title: Hydrogen-Rich Water as a Performance-Enhancing Aid in National-Level Finswimmers: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.

Super-Abstract

In 12 national-level finswimmers, four days of hydrogen-rich water (0.9 ppm) improved 400-m time-trial performance by 0.6% compared with placebo (P = .003), while 50-m sprint times showed no statistically significant difference (0.5%, P = .12). Blood lactate, perceived exertion and the oxidative stress marker plasma protein carbonyls also did not differ significantly between conditions (all P ≥ .12). The crossover trial was small, and the 400-m result rests on one time trial per condition. (Int J Sports Physiol Perform, 2026.)

Classified as a RCT study using Drinking (HRW). See Methodology for how we grade evidence.

Commentary

The study asked whether a short course of hydrogen-rich water changes swimming performance and physiological markers. Eight female and four male national-level finswimmers, with mean ages of 21 and 19 years, took part in a randomised, double-blind, placebo-controlled crossover trial. They drank hydrogen-rich water with a hydrogen concentration of 0.9 ppm, or placebo, starting 3 days before the test sessions. Intake was 1260 mL per day for 3 days and, in the abstract's wording, 1680 mL on the day before the 400-m time trial. On the test day they swam 3 sets of 4 × 50-m surface sprints in the morning and a 400-m surface time trial in the afternoon. Blood lactate and rating of perceived exertion were measured after each sprint set and after the time trial. Plasma protein carbonyls served as a marker of oxidative stress. After a 1-week washout the swimmers repeated the protocol with the other drink. The abstract does not name a primary endpoint, describe the placebo or report adverse events. The same group of swimmers and the same trial registration also appear in Sládečková 2024.

Key quotes

  1. „HRW did not significantly improve morning 50-m sprint times (0.5%, P = .12) but afternoon 400-m time trial was improved by 0.6% (P = .003).“ — the two performance results: no significant sprint effect, a small time-trial gain
  2. „The differences between HRW and placebo administration on blood lactate, rating of perceived exertion, and protein carbonyls were not significant (all P ≥ .12).“ — physiological and perceptual markers, including oxidative stress, showed no significant differences
  3. „Short-term HRW supplementation provides a modest yet meaningful performance improvement of 0.6% in middle-distance (400-m surface) finswimming. However, its effects on repeated sprint performance, blood lactate, perceived exertion, and oxidative stress appear limited.“ — the authors' conclusion: a small time-trial gain, limited effects elsewhere

Our assessment

This is a registered, randomised, double-blind crossover trial, so each swimmer served as their own control. Of the reported outcomes, only the 400-m time trial differed significantly, by 0.6%. Sprint times, blood lactate, perceived exertion and protein carbonyls showed no statistically significant differences. The authors call the time-trial gain modest yet meaningful. Whether a difference of this size holds in other swimmers or in competition cannot be judged from one small trial. Limitations: 12 participants, one 400-m time trial per condition, four days of supplementation, several outcomes without a named primary endpoint, and no information on adverse events or the placebo in the abstract.

Study design

Abstract

PURPOSE: We investigated whether a 4-day intake of hydrogen-rich water (HRW) improves finswimming performance and alters physiological and perceptual markers including blood lactate, rating of perceived exertion, and oxidative stress. METHODS: Eight females and 4 males, age 21 (5) and 19 (1) years, maximal oxygen consumption 45.0 (2.5) and 52.2 (1.7) mL·kg-1·min-1, performed 3 sets of 4 reps of 50-m surface finswimming sprints in a morning session, and a 400-m surface time trial in the afternoon on the same day. Participants consumed either HRW (hydrogen concentration 0.9 ppm) or placebo, starting 3 days prior to the experimental sessions. Intake was 1260 mL per day for 3 days, and 1680 mL on the day before the 400-m time trial. After each 4 × 50-m set and 400-m trial, blood lactate and rating of perceived exertion were measured. Oxidative stress was evaluated by plasma protein carbonyls at scheduled time points. After a 1-week washout period, the experiment was repeated with participants receiving the alternate intervention. CLINICAL TRIALS REGISTRATION: NCT05799911. RESULTS: HRW did not significantly improve morning 50-m sprint times (0.5%, P = .12) but afternoon 400-m time trial was improved by 0.6% (P = .003). The differences between HRW and placebo administration on blood lactate, rating of perceived exertion, and protein carbonyls were not significant (all P ≥ .12). CONCLUSIONS: Short-term HRW supplementation provides a modest yet meaningful performance improvement of 0.6% in middle-distance (400-m surface) finswimming. However, its effects on repeated sprint performance, blood lactate, perceived exertion, and oxidative stress appear limited.

Source & links

Screenshot of the PubMed page

Screenshot — PubMed 41991147

This page mirrors the published abstract (© the authors / publisher) for reference and citation. The canonical source is the PubMed record linked above. This is not medical advice.